Top Interview Questions and Answer for B.Pharm Fresher

1. Question 1. What Is The Responsibility Of A Pharmacist?
   Answer :
   The responsibility of a pharmacist is to
   • Manage a drug store
   • Advising patients and physicians
   • Verifying accuracy of prescription
   • Reviewing possible side effects
   • Assigning correct dosage
   • Recommending most appropriate non-prescription drug
   • Give information to the patient about drug interaction
2. Question 2. What Are The Three Qualities A Professional Pharmacist Should Have?
   Answer :
   1. Drug Management
   2. Customer Management
   3. Staff Management
3. Question 3. What Are The Record Keeping Procedures That A Pharmacist Have To Do?
   Answer :
   The record keeping procedures that a pharmacist have to do
   • Storing pharmacy files
   • Patient records
   • Inventories and update system files
   • Registries of poisons and controlled drugs
4. Question 4. What Are The Side Effects Of Methadone?
   Answer :
   The side effects of methadone are:
   • Feeling anxious, nervous or restless
   • Insomnia ( Sleeping disorder )
   • Feeling drowsy and weak
   • Nausea, vomiting, diarrhoea, constipation, loss of appetite, dry mouth
   • Impotence
5. Question 5. Classify The Controlled Drug? What Is The Storage Procedure For Controlled Drug?
   Answer :
   Controlled drug is classified into five, Schedule type 1, Schedule type 2, Schedule type 3, Schedule type 4 and Schedule 5.
   For CD drug, it should be stored into a closed cabinet made up of metal and with a lock on it.  Moreover, only authorized person should have an access to it and only he can administer the CD drug to the patient.  For home visit doctor should carry in a lockable bag.Phatmacist.
6. Question 6. Is Pharmacist Allowed To Give A Copy Of Prescription?
7. Answer :
   Yes, pharmacist is allowed to give a copy of prescription but they can only use a copy of prescription for an informational purpose only.   A pharmacist cannot dispense a drug from a copy of a prescription. They can contact your doctor to provide you with a new prescription in case you lost your prescription based on the information on the Copy of prescription.
8. Question 7. What Are The Errors That A Pharmacist Should Avoid While Dispensing Drug?
   Answer :
   • Patient’s wrong information (age, weight, allergies, pregnancy status, etc.)
   • Inaccurate drug information
   • Miscommunication between health professionals, staff and patient
   • Wrong drug labelling, packaging and nomenclature ( lookalike drug or package)
   • Inadequate education given to staff related to drugs
   • Inappropriate way of storage, standardization and distribution of drugs
   • Ignoring quality processes and risk management
   • Inappropriate way of medication delivery device acquisition
9. Question 8. What Is Warfarin And What Are Some Of The Drugs It Interacts And Should Be Avoided?
   Answer :
   Warfarin is a drug used as anti-coagulant, and it is used in patient who is at high risk of heart attack due to blood clot.
   Some of the drugs with which it interacts and should be avoided in combination with
   1. Aspirin
   2. Clopidogrel
   3. Danaproid
   4. Dipyridamole
   5. LMWHs
   6. NSAIDs
   7. Ticlopidine
   8. Unfractionated heparin
10. Question 9. What Are The Problems You Face Being A Pharmacist?
    Answer :
    • Being unable to read prescription
    • Administrating control drug and dealing with patient
    • Need to communicate with all type of people
    • To see drug interaction with prescribed drugs
11. Question 10. Explain Why Doctor Prescribes Antibiotics More For Viral Infection Instead Of Anti-viral Drugs?
    Answer :
    Doctors prescribe antibiotics without any test because most infectious disease is caused by antibiotics, though antibiotics are less effective on viral infection, at the same time it has fewer side-effects and more spectrum compare to anti-viral. Anti-viral has a narrow spectrum, which means it is effective on limited virus.  In serious condition, only anti-viral is prescribed.
12. Question 11. What Is Nabp?
13. Answer :
    NABP is the Electronic Licensure Transfer Program allows licensed pharmacists to transfer their existing pharmacist license easily from one state to another.
14. Question 12. What Are The Information Should Be There On A Prescription For Controlled Drugs?
    Answer :
    For a controlled drug prescription should cover all these information:
    • Date of Issue
    • Patient name and address
    • Practitioner name, address and DEA registration number
    • Drug name
    • Drug strength
    • Dosage form
    • Quantity prescribed
    • Directions for use
    • Number of refills authorized
    • Manual signature of the prescriber
15. Question 13. Explain Can Controlled Substance Prescription Be Refilled?
    Answer :
    Controlled substance prescription can be refilled for up to five times in six month, schedule type V can be refilled as directed by physician, while type II cannot be refilled.
16. Question 14. Is It Permissible For Controlled Drug To Dispense A Prescription For A Quantity Less Than The Face Amount?
    Answer :
    Yes, partial refill of schedules III and IV controlled substance prescriptions are accepted under federal regulations provided that partial filling is dispensed and recorded in the same manner as a refilling, the total quantity dispensed in all partial filling does not exceed the total quantity prescribed, no dispensing occurs after six months past the date of issue.
17. Question 15. Explain How Pharmacist Can Help The Patient With Asthma?
    Answer :
    Pharmacist can help the patient with Asthma by educating them and give information on it
    • Trigger management
    • Role of controller medications
    • Role of Rescue medications
    • Early detection of disease
18. Question 16. Explain What Is Peak Flow Meter?
    Answer :
    Peak flow meter is a cheap device used for assessing a patient’s current asthma control.  It helps patient to monitor the Asthma level and its severity.  It measures the peak expiratory flow (PEF) rate.
19. Question 17. Can Pharmacies Provide Ec (emergency Contraceptive) To Women Under 17 Years Old?
    Answer :
    Yes, pharmacies can dispense EC to women under 17 years old, it can be sold directly on store shelves without a prescription.
20. Question 18. Explain How You Process Your Prescription?
    Answer :
    Once the patient prescription is processed, we follow the following steps:
    Prescription Drop off: Once prescription is received, immediate communication begin with doctor and insurance company, to make sure that we have the required authorization to dispense the medicine.
    Benefits Investigation: With speciality prescription, we take additional steps and information to understand the benefit and work with patient insurance plan and doctor to get him on therapy as soon as possible
    Prescription Pickup: If patient is waiting for a prescription to be authorized, we will call to schedule a pickup at a target that is convenient for the patient
21. Question 19. Explain What Is Ncpdp?
    Answer :
    NCPDP is a National Council for Prescription Drug Program, before anything is started; a pharmacy needs to sign up with NCPDP, a database service which allows to bill. NCPDP issues a unique number to each pharmacy that identifies it for billing purposes
22. Question 20. What Is Pbm?
    Answer :
    PBM stands for Pharmacy Benefits Manager; it is often a third party administrator of prescription drug programs but sometimes can be a service inside of an integrated health care system… It is responsible for processing and paying prescription drugs.
23. Question 21. Why Pharmacist Insurance Is Important?
    Answer :
    It is more often that in case of any critical situation, doctors are sued by patients, but there are still chances that even pharmacist can be dragged. So insurance can help you pay for your legal defence and can protect your license rights.
24. Question 22.What is Regulatory Affairs?
    Regulatory Affairs in a Pharmaceutical industry, is a profession which acts as the interface between the pharmaceutical industry and Drug Regulatory authorities across the world. It is mainly involved in the registration of the drug products in respective countries prior to their marketing.
    Question 23. What are the goals of Regulatory Affairs Professionals?
    • Protection of human health
    • Ensuring safety, efficacy and quality of drugs
    • Ensuring appropriateness and accuracy of product information
    Question 24. What are the Roles of Regulatory Affairs professionals?
    • Act as a liaison with regulatory agencies
    • Preparation of organized and scientifically valid NDA, ANDA,INDA ,MAA,DMF submissions
    • Ensure adherence and compliance with all the applicable cGMP, ICH, GCP, GLP guidelines, regulations and laws
    • Providing expertise and regulatory intelligence in translating regulatory requirements into practical workable plans
    • Advising the companies on regulatory aspects and climate that would affect their proposed activities
    Question 25. What is an Investigational New Drug (IND) application?
    It is an application which is filled with FDA to get approval for legally testing an experimental drug on human subjects in the USA
    Question 26. What is a New Drug Application?
    The NDA is the vehicle through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing in the U.S.  The data gathered during the animal studies and human clinical trials of an Investigational new drug become part of the NDA
    In simple words, “It is an application which is filed with FDA to market a new Pharmaceutical for sale in USA”
    Question 27. What is an Abbreviated New Drug Application (ANDA)?
    It is an application filed with FDA, for a U.S. generic drug approval for an existing licensed medication or approved drug.
    In simple words, “It is an application for the approval of Generic Drugs “
    Question 28. What is a Generic Drug Product?
    A generic drug product is the one that is comparable to an innovator drug product in dosage form, strength, route of administration, quality, performance characteristics and intended use.
    Question 29. What is a DMF?
    A Drug Master File (DMF) is a submission to the Food and Drug Administration (FDA) that may be used to provide confidential detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of one or more human drugs.
    Important facts regarding DMFs
    It is submitted to FDA to provide confidential information
    Its submission is not required by law or regulations
    It is neither approved nor disapproved
    It is filled with FDA to support NDA, IND, ANDA another DMF or amendments and supplements to any of these
    It is provided for in the 21 CFR (Code of Federal Regulations) 314. 420
    It is not required when applicant references its own information
    Question 30. What are the types of DMF’s?
    Type I: Manufacturing Site, Facilities, Operating Procedures, and Personnel (No longer accepted by FDA)
    Type II: Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
    Type III: Packaging Material
    Type IV: Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
    Type V: FDA Accepted Reference Information (FDA discourages its use)
    Question 31. What is a 505 (b) (2) application?
    505 (b)(2) application is a type of NDA for which one or more investigations relied on by applicant for approval were not conducted by/for applicant and for which applicant has not obtained a right of reference.
    Question 32. What kind of application can be submitted as a 505(b) (2) application?
    New chemical entity (NCE)/new molecular entity (NME)
    Changes to previously approved drugs
    Question 33. What are the examples of changes to approved drug products for which 505(b)(2) application should be submitted?
    1. Change in dosage form.
    2. Change in strength
    3. Change in route of administration
    4. Substitution of an active ingredient in a formulation product
    5. Change in formulation
    6. Change in dosing regimen
    7. Change in active ingredient
    8. New combination Product
    9. New indication
    10. Change from prescription indication to OTC indication
    11. Naturally derived or recombinant active ingredient
    12. Bioinequivalence